
    
      This is a prospective multi-center, non-blinded (open label), non-randomized safety and
      feasibility study of the heterotopic implantation of the Edwards-Sapien XT or S3 valve in the
      inferior vena cava for the treatment of severe tricuspid regurgitation in patients who are
      inoperable or at a very high surgical risk for tricuspid valve replacement.
    
  